BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 19361894)

  • 1. 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.
    Kumar V; Jaggi M; Singh AT; Madaan A; Sanna V; Singh P; Sharma PK; Irchhaiya R; Burman AC
    Eur J Med Chem; 2009 Aug; 44(8):3356-62. PubMed ID: 19361894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives.
    Kumar V; Madaan A; Sanna VK; Vishnoi M; Joshi N; Singh AT; Jaggi M; Sharma PK; Irchhaiya R; Burman AC
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1169-78. PubMed ID: 19555167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives.
    Srivastava SK; Jaggi M; Singh AT; Madan A; Rani N; Vishnoi M; Agarwal SK; Mukherjee R; Burman AC
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6660-4. PubMed ID: 17950602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity.
    Roma G; Di Braccio M; Grossi G; Piras D; Ballabeni V; Tognolini M; Bertoni S; Barocelli E
    Eur J Med Chem; 2010 Jan; 45(1):352-66. PubMed ID: 19913952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridin-(5H)ones.
    Deady LW; Rogers ML; Zhuang L; Baguley BC; Denny WA
    Bioorg Med Chem; 2005 Feb; 13(4):1341-55. PubMed ID: 15670942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory activity of a naphthyridine derivative (7-chloro-6-fluoro-N-(2-hydroxy-3-oxo-1-phenyl-3-(phenylamino)propyl)-4-oxo-1-(prop-2-yn-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide) possessing in vitro anticancer potential.
    Madaan A; Kumar V; Verma R; Singh AT; Jain SK; Jaggi M
    Int Immunopharmacol; 2013 Mar; 15(3):606-13. PubMed ID: 23370301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
    Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
    Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity.
    Roma G; Grossi G; Di Braccio M; Piras D; Ballabeni V; Tognolini M; Bertoni S; Barocelli E
    Eur J Med Chem; 2008 Aug; 43(8):1665-80. PubMed ID: 18045747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,8-Naphthyridines VI. Synthesis and anti-inflammatory activity of 5-(alkylamino)-N,N-diethyl[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides with a new substitution pattern on the triazole ring.
    Di Braccio M; Grossi G; Roma G; Piras D; Mattioli F; Gosmar M
    Eur J Med Chem; 2008 Mar; 43(3):584-94. PubMed ID: 17602797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridines.
    Deady LW; Rodemann T; Zhuang L; Baguley BC; Denny WA
    J Med Chem; 2003 Mar; 46(6):1049-54. PubMed ID: 12620081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
    Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.
    Manera C; Malfitano AM; Parkkari T; Lucchesi V; Carpi S; Fogli S; Bertini S; Laezza C; Ligresti A; Saccomanni G; Savinainen JR; Ciaglia E; Pisanti S; Gazzerro P; Di Marzo V; Nieri P; Macchia M; Bifulco M
    Eur J Med Chem; 2015 Jun; 97():10-8. PubMed ID: 25935384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cytostatic properties of some 6H-Indolo[2, 3-b][1, 8]naphthyridine derivatives.
    Mastalarz H; Jasztold-Howorko R; Rulko F; Croisy A; Carrez D
    Arch Pharm (Weinheim); 2004 Aug; 337(8):434-9. PubMed ID: 15293262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells.
    Banti I; Nencetti S; Orlandini E; Lapucci A; Breschi MC; Fogli S
    J Pharm Pharmacol; 2009 Aug; 61(8):1057-66. PubMed ID: 19703350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, anti-inflammatory and anticancer activity evaluation of some novel acridine derivatives.
    Sondhi SM; Singh J; Rani R; Gupta PP; Agrawal SK; Saxena AK
    Eur J Med Chem; 2010 Feb; 45(2):555-63. PubMed ID: 19926172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative activity of novel benzo[b][1,6]naphthyridines in human solid tumor cell lines.
    Rudys S; Ríos-Luci C; Pérez-Roth E; Cikotiene I; Padrón JM
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1504-6. PubMed ID: 20144871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents.
    Tsuzuki Y; Tomita K; Sato Y; Kashimoto S; Chiba K
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3189-93. PubMed ID: 15149673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
    Tsuzuki Y; Tomita K; Shibamori K; Sato Y; Kashimoto S; Chiba K
    J Med Chem; 2004 Apr; 47(8):2097-109. PubMed ID: 15056007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model.
    Bilodeau MT; Balitza AE; Hoffman JM; Manley PJ; Barnett SF; Defeo-Jones D; Haskell K; Jones RE; Leander K; Robinson RG; Smith AM; Huber HE; Hartman GD
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3178-82. PubMed ID: 18479914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines.
    Chandrika PM; Yakaiah T; Rao AR; Narsaiah B; Reddy NC; Sridhar V; Rao JV
    Eur J Med Chem; 2008 Apr; 43(4):846-52. PubMed ID: 17689837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.